Scholars Central

Conference abstractPublished 18 Aug 2016

Glucose 6 phosphate dehydrogenase (G6PD) enzyme deficiency in jaundiced infants in Khyber Pakhtunkhwa

Authors: Shahtaj Khan

Hayatabad Medical Complex, Pakistan

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Objective: The aim of this study was to evaluate the prevalence of G6PD deficiency by G6PD quantitative method in jaundice infants coming from different districts of Khyber Pakhtunkhwa (KPK). Materials & Methods: In this descriptive cross sectional study total no of three hundred (Male n=200, Female n=100) hyperbilirubinemia infants of <01 year were randomly selected for the study. By aseptic technique 4 ml blood was collected, 2 ml for bilirubin profile and 2 ml for G6PD enzyme assay. Serum bilirubin was determined by Diazo reaction method using Architect plus ci8200 (Abbott, USA) and G6PD quantitative enzyme assay was measured by ultraviolet kinetic method (Trinity biotech kit, USA). The collected data was recorded and analyzed in SPSS-20.P value was less than 0.005, it was considered as statistically significant. Results: With this study 33 (11%) jaundiced infants were G6PD deficient and 267 (89%) infants were normal G6PD level. In all male jaundice neonates 25 (12.5%) were G6PD deficient and 175 (87.5%) with normal G6PD quantity, while 08 (08%) female infants were G6PD deficient and 92 (92%) within normal G6PD range out of all jaundiced female infants. No significant differences in G6PD enzyme level were seen among male and female jaundiced infants. The mean serum total bilirubin in G6PD deficient neonates and normal infants was 13.8 mg/dl and 12.2 mg/dl respectively. Conclusion: Our study concluded that 11% of infants presenting with jaundice were G6PD deficient, which is a higher percentage. As the study was conducted in our area, which is endemic for malaria and poverty leads to frequent episodes of infection, certain drugs can cause fatal hemolysis. So as per WHO protocol our population needs screening for G6PD deficiency. We suggest that quantitative G6PD levels should be done at least prior to anti-malarial therapy in every infant.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectBiochemistry & Biotechnology
  • SubjectPaediatrics & Neonatology
  • BylineArticles whose byline prints “Shahtaj Khan”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels